Trends in childhood leukemia in Basrah, Iraq, 1993-2007.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 2866604)

Published in Am J Public Health on February 18, 2010

Authors

Amy Hagopian1, Riyadh Lafta, Jenan Hassan, Scott Davis, Dana Mirick, Tim Takaro

Author Affiliations

1: Department of Global Health, School of Public Health, University of Washington, 4534 11th Avenue NE, Seattle, WA 98105, USA. hagopian@u.washington.edu

Articles cited by this

Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet (2004) 5.64

Violence-related mortality in Iraq from 2002 to 2006. N Engl J Med (2008) 5.43

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res (1994) 4.15

Sanctions and childhood mortality in Iraq. Lancet (2000) 3.90

Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer (2008) 3.71

Case-control study of leukaemia and non-Hodgkin's lymphoma among children aged 0-4 years living in west Berkshire and north Hampshire health districts. BMJ (1993) 2.80

Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst (1999) 2.38

Benzene and leukemia. A review of the literature and a risk assessment. Am J Epidemiol (1988) 2.36

Socioeconomic status and childhood leukaemia: a review. Int J Epidemiol (2005) 2.30

Childhood cancer epidemiology in low-income countries. Cancer (2008) 1.74

High-contact paternal occupations, infection and childhood leukaemia: five studies of unusual population-mixing of adults. Br J Cancer (1997) 1.65

Mixed messages about depleted uranium. Lancet Oncol (2001) 1.50

Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet (2001) 1.42

Drinking water contaminants and childhood leukemia. Epidemiology (2001) 1.37

Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphomas in childhood: a case-control study. Tumori (1990) 1.33

Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst (1995) 1.28

Childhood cancers in Chennai, India, 1990-2001: incidence and survival. Int J Cancer (2008) 1.24

Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: importance of the Cancer registry (a population-based study). BMC Cancer (2007) 1.07

Parental and infant characteristics and childhood leukemia in Minnesota. BMC Pediatr (2008) 1.02

Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol (2004) 0.99

Childhood cancer in Ireland: a population-based study. Arch Dis Child (2007) 0.99

Father's occupational exposure to carcinogenic agents and childhood acute leukemia: a new method to assess exposure (a case-control study). BMC Cancer (2008) 0.95

Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction. Am J Public Health (2005) 0.93

Bayesian methods for early detection of changes in childhood cancer incidence: trends for acute lymphoblastic leukaemia are consistent with an infectious aetiology. Eur J Cancer (2005) 0.90

Maxillofacial war injuries during the Iraq-Iran War: an analysis of 300 cases. Int J Oral Maxillofac Surg (2003) 0.89

Parental occupational exposure and the risk of acute lymphoblastic leukemia in offspring in Israel. J Occup Environ Med (2006) 0.86

Descriptive epidemiology of de novo acute leukaemia in the Sultanate of Oman. Leuk Res (2000) 0.84

Childhood leukaemias and lymphomas in Greece (1996-2006): a nationwide registration study. Arch Dis Child (2008) 0.84

Polycyclic aromatic hydrocarbons, nickel and vanadium in air particulate matter in Bahrain during the burning of oil fields in Kuwait. Sci Total Environ (1992) 0.82

Articles by these authors

(truncated to the top 100)

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41

Mortality after the 2003 invasion of Iraq: a cross-sectional cluster sample survey. Lancet (2006) 9.94

Mortality before and after the 2003 invasion of Iraq: cluster sample survey. Lancet (2004) 8.32

Implementation of the Women's Health Initiative study design. Ann Epidemiol (2003) 7.30

Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81

Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot (2006) 3.03

Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science (2014) 2.77

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27

Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev (2004) 2.19

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood (2006) 2.15

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res (2006) 2.06

The GENESIS project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. J Intensive Care Med (2012) 2.05

Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood (2006) 2.02

Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01

The impact of chronotype on melatonin levels among shift workers. Occup Environ Med (2014) 2.00

Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94

Organochlorines in carpet dust and non-Hodgkin lymphoma. Epidemiology (2005) 1.89

Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87

Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol (2013) 1.82

Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab (2008) 1.77

Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites. J Expo Anal Environ Epidemiol (2004) 1.76

Iraq War mortality estimates: a systematic review. Confl Health (2008) 1.72

Health services in Iraq. Lancet (2013) 1.66

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood (2007) 1.63

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58

Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood (2010) 1.56

Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma. Cancer Res (2005) 1.55

Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One (2009) 1.52

A method for cross-species gene expression analysis with high-density oligonucleotide arrays. Nucleic Acids Res (2004) 1.51

Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J Psychosom Res (2005) 1.47

Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45

Doctors leaving 12 tertiary hospitals in Iraq, 2004-2007. Soc Sci Med (2009) 1.43

Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control (2006) 1.38

Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol (2005) 1.36

Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer (2004) 1.32

Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood (2007) 1.30

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood (2008) 1.26

Childhood thyroid cancer, radiation dose from Chernobyl, and dose uncertainties in Bryansk Oblast, Russia: a population-based case-control study. Radiat Res (2006) 1.26

Residential herbicide use and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2005) 1.24

Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res (2009) 1.22

Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr (2006) 1.22

Transcriptomes of the B and T lineages compared by multiplatform microarray profiling. J Immunol (2011) 1.22

Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control (2005) 1.20

Recreational water-related illness: office management and prevention. Can Fam Physician (2013) 1.19

Response to Ijaz S, et al. "Night-shift work and breast cancer--a systematic review and meta-analysis". Scand J Work Environ Health (2013) 1.18

Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev (2009) 1.17

Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res (2007) 1.17

Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis (2006) 1.16

Isotope ratios of H, C, and O in CO2 and H2O of the martian atmosphere. Science (2013) 1.15

Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study. Carcinogenesis (2005) 1.14

Melatonin as a biomarker of circadian dysregulation. Cancer Epidemiol Biomarkers Prev (2008) 1.13

Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenet Genomics (2006) 1.12

Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer (2010) 1.12

A case-control study of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health Perspect (2011) 1.10

Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.09

2012 white paper on recent issues in bioanalysis and alignment of multiple guidelines. Bioanalysis (2012) 1.09

A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis (2008) 1.08

Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology (2008) 1.06

Residential insecticide use and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev (2006) 1.05

Where's the pump? Associating sporadic enteric disease with drinking water using a geographic information system, in British Columbia, Canada, 1996-2005. J Water Health (2009) 1.05

Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control (2007) 1.04

Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med (2004) 1.01

Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood (2009) 1.01

Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006. Am J Hematol (2010) 1.01

Estimation of thyroid radiation doses for the hanford thyroid disease study: results and implications for statistical power of the epidemiological analyses. Health Phys (2004) 0.99

Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges. Ann N Y Acad Sci (2011) 0.99

A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers. Cancer Causes Control (2007) 0.96

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer. Breast Cancer Res Treat (2010) 0.95

The relationship between multiple myeloma and occupational exposure to six chlorinated solvents. Occup Environ Med (2010) 0.95

Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J Atheroscler Thromb (2009) 0.95

ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout. Thyroid (2008) 0.94

Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst (2002) 0.93

A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. Br J Haematol (2011) 0.93

Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer (2005) 0.93

Risk of subsequent breast cancer in relation to characteristics of screening mammograms from women less than 50 years of age. Cancer Epidemiol Biomarkers Prev (2002) 0.93

Dietary flavonoid intake and non-Hodgkin lymphoma risk. Am J Clin Nutr (2008) 0.93

A method for gene expression analysis by oligonucleotide arrays from minute biological materials. Anal Biochem (2004) 0.93

Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men. Cancer Epidemiol Biomarkers Prev (2013) 0.92

Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. Blood (2008) 0.92

Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk. Cancer Causes Control (2008) 0.91

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol (2015) 0.91

Birth order and risk of non-hodgkin lymphoma--true association or bias? Am J Epidemiol (2010) 0.91

Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer (2008) 0.90

Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma. Cancer Causes Control (2009) 0.90

Lifetime occupational history and risk of endometriosis. Scand J Work Environ Health (2009) 0.90

Coordination of behavioral hierarchies during environmental transitions in Caenorhabditis elegans. Worm (2012) 0.90

Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Res (2010) 0.89

Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. Br J Haematol (2010) 0.89

A method for determining zygosity of transgenic zebrafish by TaqMan real-time PCR. Anal Biochem (2005) 0.88

Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2010) 0.88

In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's disease. J Med Chem (2010) 0.87

Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer (2010) 0.87

Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat Res (2006) 0.86

Dynamic pupillometry as an autonomic testing tool. Clin Auton Res (2013) 0.85

Cyclin D1 splice variant and risk for non-Hodgkin lymphoma. Hum Genet (2006) 0.85